Usha K. Dutta

Dr. Usha K. Dutta

orcid

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 July 2020 in Hepatology International
Verified
Journal Article
Closed access
PDF file
PKPraveen Kumar-M
Praveen Kumar-M
SMShubhra Mishra
Shubhra Mishra
DJDaya Krishna Jha
Daya Krishna Jha
JSJayendra Shukla
Jayendra Shukla
ACArup Choudhury
Arup Choudhury
VSVishal Sharma
Vishal Sharma

22 March 2012 in Journal of Gastroenterology and Hepatology
Verified
Journal Article
Closed access
PDF file
UDUsha K. Dutta
Usha K. Dutta

30 January 2022 in Intestinal Research
Verified
Journal Article
Open access
PDF file
ASArshdeep Singh
Arshdeep Singh
RMRamit Mahajan
Ramit Mahajan
SKSaurabh Kedia
Saurabh Kedia
ADAmit Kumar Dutta
Amit Kumar Dutta
AAAbhinav Anand
Abhinav Anand
ASAjit Sood
Ajit Sood
Inflammatory bowel disease (IBD), once considered a disease of the Western hemisphere, has emerged as a global disease. As the disease prevalence is on a steady rise, management of IBD has come under the spotlight. 5-Aminosalicylates, corticosteroids, immunosuppressive agents and biologics are the backbone of treatment of IBD. With the advent of biologics and small molecules, the need for surgery and hospitalization has decreased. However, economic viability and acceptability is an important determinant of local prescription patterns. Nearly one-third of the patients in West receive biologics as the first/initial therapy. The scenario is different in developing countries where biologics are used only in a small proportion of patients with IBD. Increased risk of reactivation of tuberculosis and high cost of the therapy are limitations to their use. Thiopurines hence become critical for optimal management of patients with IBD in these regions. However, approximately one-third of patients are intolerant or develop adverse effects with their use. This has led to suboptimal use of thiopurines in clinical practice. This review article discusses the clinical aspects of thiopurine use in patients with IBD with the aim of optimizing their use to full therapeutic potential.

11 June 2008
Verified
Journal Article
Closed access
UGUday C Ghoshal
Uday C Ghoshal
PAPhilip Abraham
Philip Abraham
CBChetan Bhatt
Chetan Bhatt
GCGourdas Choudhuri
Gourdas Choudhuri
SBShobna J Bhatia
Shobna J Bhatia
JVJ C Vij
J C Vij

17 April 2019 in JGH Open
Verified
Journal Article
Open access
PDF file
ABAkash Bansal
Akash Bansal
GPGupta Pankaj
Gupta Pankaj
HSHarjeet Singh
Harjeet Singh
JSJayanta Samanta
Jayanta Samanta
HMHarshal Mandavdhare
Harshal Mandavdhare
RKRakesh Kochhar
Rakesh Kochhar
Pancreatitis is one of the important medical conditions. Gastrointestinal (GI) complications of pancreatitis are important and lead to significant morbidity and mortality. Diagnosis of these complications is difficult and may require a strong clinical suspicion coupled with various imaging features. This review provides an extensive update of the whole spectrum of GI complication of pancreatitis, both acute and chronic, from inflammation, ischemia, and necrosis to obstruction, perforation, and GI fistulae. The focus is on the clinical and imaging features of this less commonly described aspect of pancreatitis.

20 September 2020 in Expert Review of Anti-infective Therapy
Verified
Journal Article
Closed access
VSVishal Sharma
Vishal Sharma
HSHariom Soni
Hariom Soni
PKPraveen Kumar-M
Praveen Kumar-M
SDSaurabh Dawra
Saurabh Dawra
SMShubhra Mishra
Shubhra Mishra
UDUsha K. Dutta
Usha K. Dutta
We performed a meta-analysis to determine diagnostic accuracy of Xpert MTB/RIF for diagnosis of abdominal (intestinal or peritoneal) tuberculosis (TB) in various tissues (intestinal, omental/perito...